A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection - Related Studies

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

This study has been completed.

Study NCT00002270. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Leukoencephalopathy, Progressive Multifocal

3	More general conditions related to this trial
		Central Nervous System Diseases
		Central Nervous System Infections
		Central Nervous System Viral Diseases
		Demyelinating Diseases
		DNA Virus Infections
		Encephalitis
		Encephalitis, Viral
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Nervous System Diseases
		Polyomavirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Interferon alfa-2b
		Zidovudine

5	Additional drug interventions recognized in this trial
		Interferon Alfa-2a
		Interferon-alpha
		Interferons

6	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antimetabolites
		Antineoplastic Agents
		Antiviral Agents
		Enzyme Inhibitors
		Growth Inhibitors
		Growth Substances
		Immunologic Factors
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reverse Transcriptase Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		University of Miami